| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8217005 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 8 Pages |
Abstract
Most patients with T4a larynx cancer receive LP-CRT, despite guidelines suggesting TL as the preferred initial approach. Patients receiving LP-CRT had more advanced nodal disease and worse overall survival. Previous studies of (non-T4a) locally advanced larynx cancer showing no difference in survival between LP-CRT and TL may not apply to T4a disease, and patients should be counseled accordingly.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Surbhi MD, MPH, Samuel MD, MSHP, Nandita PhD, Jiaqi BS, Roger B. MD, Peter H. MD, John N. MD, Ara A. MD, Gregory S. MD, Bert W. MD, Alexander MD,